Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02906059
Title Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors New York University School of Medicine
Indications

colorectal cancer

Therapies

Adavosertib + Irinotecan

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST